WO2015013455A3 - Methods and compositions for the treatment and diagnosis of cancer - Google Patents

Methods and compositions for the treatment and diagnosis of cancer Download PDF

Info

Publication number
WO2015013455A3
WO2015013455A3 PCT/US2014/047902 US2014047902W WO2015013455A3 WO 2015013455 A3 WO2015013455 A3 WO 2015013455A3 US 2014047902 W US2014047902 W US 2014047902W WO 2015013455 A3 WO2015013455 A3 WO 2015013455A3
Authority
WO
WIPO (PCT)
Prior art keywords
methods
cancer
diagnosis
compositions
treatment
Prior art date
Application number
PCT/US2014/047902
Other languages
French (fr)
Other versions
WO2015013455A2 (en
Inventor
Karen Chapman
Joseph Wagner
Michael West
Original Assignee
Oncocyte Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncocyte Corp filed Critical Oncocyte Corp
Publication of WO2015013455A2 publication Critical patent/WO2015013455A2/en
Publication of WO2015013455A3 publication Critical patent/WO2015013455A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The invention relates to methods of detecting cancer in a sample obtained from a subject. The invention also provides kits and reagents for detecting cancer as well as therapeutics and methods of treating cancer.
PCT/US2014/047902 2013-07-23 2014-07-23 Methods and compositions for the treatment and diagnosis of cancer WO2015013455A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361857390P 2013-07-23 2013-07-23
US61/857,390 2013-07-23

Publications (2)

Publication Number Publication Date
WO2015013455A2 WO2015013455A2 (en) 2015-01-29
WO2015013455A3 true WO2015013455A3 (en) 2015-11-05

Family

ID=52393974

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2014/047902 WO2015013455A2 (en) 2013-07-23 2014-07-23 Methods and compositions for the treatment and diagnosis of cancer

Country Status (1)

Country Link
WO (1) WO2015013455A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018054783A1 (en) * 2016-09-16 2018-03-29 Qiagen Gmbh Method for quantifying and/or detecting human male dna
US11236337B2 (en) 2016-11-01 2022-02-01 The Research Foundation For The State University Of New York 5-halouracil-modified microRNAs and their use in the treatment of cancer

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100113297A1 (en) * 2007-02-26 2010-05-06 Centre Rene Huguenin Method for predicting the occurrence of metastasis in breast cancer patients
WO2012178128A1 (en) * 2011-06-22 2012-12-27 Oncocyte Corporation Methods and compositions for the treatment and diagnosis of cancer

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100113297A1 (en) * 2007-02-26 2010-05-06 Centre Rene Huguenin Method for predicting the occurrence of metastasis in breast cancer patients
WO2012178128A1 (en) * 2011-06-22 2012-12-27 Oncocyte Corporation Methods and compositions for the treatment and diagnosis of cancer

Also Published As

Publication number Publication date
WO2015013455A2 (en) 2015-01-29

Similar Documents

Publication Publication Date Title
WO2013033609A3 (en) Methods and compositions for the treatment and diagnosis of cancer
WO2015061634A3 (en) Biomarkers and diagnostic methods for alzheimer's disease and other neurodegenerative disorders
WO2017049251A3 (en) Therapeutic cd47 antibodies
MX2021001659A (en) Neuroactive steroids, compositions, and uses thereof.
MX2020008976A (en) Biomarkers and methods of treating pd-1 and pd-l1 related conditions.
EP2825669A4 (en) Methods and compositions for the diagnosis, prognosis and treatment of acute myeloid leukemia
WO2013033627A3 (en) Diagnosis and treatment of arthritis using epigenetics
MX2017010836A (en) Biomarker panel for the detection of cancer.
GB2511221A (en) Methods and compositions for classification of samples
WO2014144822A3 (en) Methods and compositions for tagging and analyzing samples
EP2714081A4 (en) Methods, compositions, and kits for the treatment of cancer
WO2015094995A3 (en) Gene signature biomarkers of tumor response to pd-1 antagonists
WO2010062377A3 (en) Methods and compositions for the detection and treatment of preeclampsia
WO2014031859A3 (en) Compositions and methods relating to blood-based biomarkers of breast cancer
WO2013106747A3 (en) Methods and compositions for the treatment and diagnosis of thyroid cancer
WO2015094996A3 (en) Pd-l1 gene signature biomarkers of tumor response to pd-1 antagonists
EP2723866A4 (en) Methods for the prognostic and/or diagnostic of neurodegenerative disease, methods to identify candidate compounds and compounds for treating neurodegenerative disease
EP2996721A4 (en) Methods and compositions for prognosis, diagnosis and treatment of adam8-expressing cancer
WO2014205266A3 (en) Compositions and methods for detecting and treating glioblastoma
WO2015070001A3 (en) Compositions and methods for detecting and/or treating inflammation
WO2014197835A3 (en) Methods and compositions for the treatment of cancer
WO2015073896A3 (en) Biomarkers for psma targeted therapy for prostate cancer
WO2015013508A3 (en) Methods for diagnosing and treating immune disease
WO2013052108A3 (en) Methods and compositions for the treatment and diagnosis of ovarian cancer
WO2015168602A3 (en) Methods and compositions for the diagnosis and treatment of kawasaki disease

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 14830149

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 14830149

Country of ref document: EP

Kind code of ref document: A2